Stay updated on Gebasaxturev Combo in Melanoma Clinical Trial
Sign up to get notified when there's something new on the Gebasaxturev Combo in Melanoma Clinical Trial page.

Latest updates to the Gebasaxturev Combo in Melanoma Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe ClinicalTrials.gov page footer now identifies the site revision as v3.8.0 instead of v3.7.2.SummaryDifference0.0%

- Check17 days agoChange DetectedA banner announces an NIH website transition and says the agency is using “Super Intelligence” (SI) in place of “Artificial Intelligence” (AI) during the transition.SummaryDifference0.4%

- Check23 days agoChange DetectedThe ClinicalTrials.gov page footer now identifies the site revision as v3.7.2 instead of v3.7.1.SummaryDifference0.1%

- Check30 days agoChange DetectedThe site footer revision changed from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check51 days agoChange DetectedThe study's record history gains a new revision entry for v3.7.0, while the older v3.6.6 entry is removed from the history.SummaryDifference0.1%

- Check73 days agoChange DetectedThe page’s revision label changed from v3.6.5 to v3.6.6, indicating a new build of the study history interface.SummaryDifference0.1%

Stay in the know with updates to Gebasaxturev Combo in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Gebasaxturev Combo in Melanoma Clinical Trial page.